NCT00703872View on ClinicalTrials.gov

HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Chronic Hepatitis C
Interventions
DRUG

Oral HDV-Interferon + ribavarin

Naive pateints

DRUG

Injectable HDV-Interferon + ribavarin

Nonresponders

Trial Locations (1)

500 004

Global Hospitals, Lakdi-ka-Pool

Sponsors
All Listed Sponsors
lead

Hepasome Pharmaceuticals

INDUSTRY

NCT00703872 - HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients | Biotech Hunter | Biotech Hunter